SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Alaunos Therapeutics Regains Nasdaq Equity Compliance

Alaunos Therapeutics said it regained compliance with Nasdaq’s stockholders’ equity requirement, allowing its common stock to remain listed and traded on the Nasdaq Capital Market.

TCRT

Related stories